Factor X analogues with a modified protease cleavage site
US6573071B1 · kind B1 · utility
17Cited by
4References
64Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 1999 |
| Grant date | Jun 3, 2003 |
| Priority date | — |
| Expiry date | Nov 12, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Factor X analogues having a modification in the region of the natural Factor Xa activation cleavage site, said modification representing a processing site of a protease not naturally cleaving in this region of the Factor X sequence, preparations containing the Factor X analogues according to the invention, and processes for the preparation thereof are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.